У нас вы можете посмотреть бесплатно Dr. Amit Bhatt: Esophageal Endoscopic Submucosal Dissection with Eleview™ или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
An esophageal endoscopic submucosal dissection is performed with Eleview™, a submucosal injection agent. Procedural steps include: 1. The esophageal lesion is identified under NBI. 2. The lesion is demarcated using electrocautery. 3. A semi-circumferential mucosal incision is made proximally. 4. Eleview™ solution is injected on the distal side of the lesion. 5. A semi-circumferential mucosal incision is made distally. 6. Creation of a submucosal tunnel from proximal to distal is shown. 7. The dissection of the submucosa is lateral to the tunnel. 8. Lateral borders are incised to achieve an en bloc resection, showing the curative resection of a 7-cm T1a esophageal squamous cell cancer. 9. A follow-up evaluation of the resection is shown, 3 months post- operatively. Eleview™ is a ready-to-use submucosal injection agent for assisting in the endoscopic removal of lesions, such as colon polyps and adenomas in the gastrointestinal tract. It is designed to help endoscopists improve their procedural capability and reduce complications. When the endoscopist finds polyps or adenomas, Eleview™ is injected into the submucosa of the gastrointestinal tract, under the lesion, providing lift of the mucosal layer and forming a safety cushion between the two layers. Physician: Amit Bhatt, MD, Cleveland Clinic Intended use: Eleview™ submucosal injectable composition is intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers, or other gastrointestinal mucosal lesions, prior to excision with a snare or endoscopic device. Aries Pharmaceuticals, Inc. is a wholly owned subsidiary of Aries Pharmaceuticals, Ltd., which is a wholly owned subsidiary of Cosmo Pharmaceuticals, NV, a specialty pharmaceutical company focused on developing and commercializing best-in-class products in endoscopy and treating gastrointestinal diseases. Aries is the US distributor of Cosmo Pharmaceutical products. Visit our About Page to learn more about Aries Pharmaceuticals, Inc. and Eleview: / @ariespharmaceuticalsinc.5383 Subscribe to our channel to be updated when new videos are added. Let’s connect Aries Pharmaceuticals, Inc.: http://www.aries-pharma.com/ Eleview™: http://eleviewus.com/ Cosmo Pharmaceuticals: http://www.cosmopharmaceuticals.com/ LinkedIn: / 1098. . Twitter: / cosmo_pharma Important Safety Information Warnings and Precautions • The endoscopist injecting Eleview™ must be experienced in the administration technique. • The safety of Eleview™ has not been established in pregnant or lactating women, or in children under 18 years of age. Please see Eleview™ Instructions for Use for complete Important Safety Information at eleviewUS.com.